{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T15:32:59Z","timestamp":1774279979734,"version":"3.50.1"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.01360","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T15:12:56Z","timestamp":1597331576000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Expression of PD-L1 on Monocytes Is a Novel Predictor of Prognosis in Natural Killer\/T-Cell Lymphoma"],"prefix":"10.3389","volume":"10","author":[{"given":"Xue-wen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-wen","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan-pan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze-long","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"De-xin","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-qi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-an","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,6]]},"reference":[{"key":"B1","first-page":"285","article-title":"Extranodal NK\/T-cell lymphoma, nasal type","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Chan","year":"2008"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1182\/blood-2016-03-657379","article-title":"Introduction to a review series: the 2016 revision of the WHO classification of tumors of hematopoietic and lymphoid tissues","volume":"127","author":"Cazzola","year":"2016","journal-title":"Blood."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the world health organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00277-015-2336-9","article-title":"Treatment outcome of patients with advanced stage natural killer\/T-cell lymphoma: elucidating the effects of asparaginase and postchemotherapeutic radiotherapy","volume":"94","author":"Bi","year":"2015","journal-title":"Ann Hematol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s12185-012-1174-y","article-title":"Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE\/IIE extranodal natural killer\/T cell lymphoma, nasal type: 13-year follow-up in 135 patients","volume":"96","author":"Wang","year":"2012","journal-title":"Int J Hematol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1182\/blood-2010-09-307454","article-title":"Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK\/T-cell lymphoma, a phase 2 study","volume":"117","author":"Jaccard","year":"2011","journal-title":"Blood."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1182\/blood-2012-05-431460","article-title":"SMILE for natural killer\/T-cell lymphoma: analysis of safety and efficacy from the Asia lymphoma study group","volume":"120","author":"Kwong","year":"2012","journal-title":"Blood."},{"key":"B8","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","article-title":"Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)\/T-cell lymphoma, nasal type: the NK-cell tumor study group study","volume":"29","author":"Yamaguchi","year":"2011","journal-title":"J Clin Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/ajh.21256","article-title":"Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK\/T-cell lymphoma, nasal type","volume":"83","author":"Wang","year":"2008","journal-title":"Am J Hematol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/annonc\/mdn551","article-title":"Effective second-line chemotherapy for extranodal NK\/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone","volume":"20","author":"Kim","year":"2009","journal-title":"Ann Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1200\/JOP.2015.009191","article-title":"Where do programmed death-1 inhibitors fit in the management of malignant lymphoma?","volume":"12","author":"Ansell","year":"2016","journal-title":"J Oncol Pract."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N Engl J Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.lungcan.2016.05.001","article-title":"Clinicopathological and prognostic significance of programmed cell death ligand-1 expression in lung adenocarcinoma and its relationship with p53 status","volume":"97","author":"Cha","year":"2016","journal-title":"Lung Cancer."},{"key":"B14","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s11899-018-0484-4","article-title":"Checkpoint inhibitors hodgkin lymphoma and non-hodgkin lymphoma","volume":"13","author":"Hu","year":"2018","journal-title":"Curr Hematol Malig Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.critrevonc.2017.02.027","article-title":"The role of anti-PD-1 and anti-PD-L1 agents in the treatment of diffuse large B-cell lymphoma: the future is now","volume":"113","author":"Juarez-Salcedo","year":"2017","journal-title":"Crit Rev Oncol Hematol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1182\/blood-2015-02-629600","article-title":"Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma","volume":"126","author":"Kiyasu","year":"2015","journal-title":"Blood."},{"key":"B17","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00262-017-1987-x","article-title":"Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer\/T-cell lymphoma: a potential rationale for immunotherapy","volume":"66","author":"Nagato","year":"2017","journal-title":"Cancer Immunol Immunother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13045-016-0341-7","article-title":"PD-L1 is upregulated by EBV-driven LMP1 through NF-kappaB pathway and correlates with poor prognosis in natural killer\/T-cell lymphoma","volume":"9","author":"Bi","year":"2016","journal-title":"J Hematol Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13045-018-0559-7","article-title":"Activity of pembrolizumab in relapsed\/refractory NK\/T-cell lymphoma","volume":"11","author":"Li","year":"2018","journal-title":"J Hematol Oncol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1182\/blood-2016-12-756841","article-title":"PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK\/T-cell lymphoma failing l-asparaginase","volume":"129","author":"Kwong","year":"2017","journal-title":"Blood."},{"key":"B21","doi-asserted-by":"publisher","first-page":"5350","DOI":"10.1200\/JCO.2006.06.4766","article-title":"Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients","volume":"24","author":"Alvaro","year":"2006","journal-title":"J Clin Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nature11183","article-title":"Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion","volume":"487","author":"Straussman","year":"2012","journal-title":"Nature."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1186\/s12885-018-5082-2","article-title":"Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells","volume":"18","author":"Pelizzo","year":"2018","journal-title":"BMC Cancer."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.3390\/cancers11020185","article-title":"In vivo cell fusion between mesenchymal stroma\/stem-like cells and breast cancer cells","volume":"11","author":"Melzer","year":"2019","journal-title":"Cancers."},{"key":"B25","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/ncb2432","article-title":"Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia","volume":"14","author":"Zhang","year":"2012","journal-title":"Nat Cell Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1093\/jnci\/djy234","article-title":"Impact of epithelial-stromal interactions on peritumoral fibroblasts in ductal carcinoma in situ","volume":"111","author":"Strell","year":"2019","journal-title":"J Natl Cancer Inst."},{"key":"B27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/imm.12117","article-title":"Human dendritic cell subsets","volume":"140","author":"Collin","year":"2013","journal-title":"Immunology."},{"key":"B28","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1158\/2326-6066.CIR-13-0094","article-title":"Untreated stage IV melanoma patients exhibit abnormal monocyte phenotypes and decreased functional capacity","volume":"2","author":"Chavan","year":"2014","journal-title":"Cancer Immunol Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/ijc.25969","article-title":"Monocytes enhance cell proliferation and LMP1 expression of nasal natural killer\/T-cell lymphoma cells by cell contact-dependent interaction through membrane-bound IL-15","volume":"130","author":"Ishii","year":"2012","journal-title":"Int J Cancer."},{"key":"B30","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/1878-0261.12032","article-title":"Chemotherapy induces tumor immune evasion by upregulation of programmed cell death ligand 1 expression in bone marrow stromal cells","volume":"11","author":"Yang","year":"2017","journal-title":"Mol Oncol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1111\/jcmm.14057","article-title":"One method to establish epstein-barr virus-associated NK\/T cell lymphoma mouse models","volume":"23","author":"Xue","year":"2019","journal-title":"J Cell Mol Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00277-017-3127-2","article-title":"PD1 blockade with low-dose nivolumab in NK\/T cell lymphoma failing L-asparaginase: efficacy and safety","volume":"97","author":"Chan","year":"2018","journal-title":"Ann Hematol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00277-016-2818-4","article-title":"Expression of programmed cell death 1 and programmed cell death ligand 1 in extranodal NK\/T-cell lymphoma, nasal type","volume":"96","author":"Jo","year":"2017","journal-title":"Ann Hematol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e1026530","DOI":"10.1080\/2162402X.2015.1026530","article-title":"Several immune escape patterns in non-hodgkin's lymphomas","volume":"4","author":"Laurent","year":"2015","journal-title":"Oncoimmunology."},{"key":"B35","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1158\/0008-5472.CAN-12-2606","article-title":"PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer","volume":"73","author":"Badoual","year":"2013","journal-title":"Cancer Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"6672","DOI":"10.1128\/JVI.00825-14","article-title":"HIV-1 Tat protein induces PD-L1 (B7-H1) expression on dendritic cells through tumor necrosis factor alpha- and toll-like receptor 4-mediated mechanisms","volume":"88","author":"Planes","year":"2014","journal-title":"J Virol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.prp.2018.03.001","article-title":"Expression of programmed cell death 1\/programmed cell death ligand 1 in the tumor microenvironments of primary gastrointestinal diffuse large B cell lymphomas","volume":"214","author":"Liu","year":"2018","journal-title":"Pathol Res Pract."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1056\/NEJMoa1809615","article-title":"Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer","volume":"379","author":"Schmid","year":"2018","journal-title":"N Engl J Med."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.01360\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T15:12:58Z","timestamp":1597331578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.01360\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,6]]},"references-count":38,"alternative-id":["10.3389\/fonc.2020.01360"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.01360","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,6]]},"article-number":"1360"}}